New information out of an Australian research facility is cautioning pregnant women that any kind of hypertensive disorder of pregnancy during their term could result in cardiovascular complications in the future.

Empagliflozin tablets reduced the risk of cardiovascular death by 38 percent in people with type 2 diabetes and established cardiovascular disease (CVD), according to a randomized, placebo-controlled trial of more than 7,000 patients. And new analyses demonstrate a similar benefit was seen in all patients, regardless of blood sugar levels at baseline or after the introduction of background treatment.

Socioeconomic stress could have a major impact on black young adults’ heart health, according to a new study published in the Journal of the American Heart Association.

Having worked with spinal injury patients for more than a decade, Anthony Gallahar knows plenty about the concept of caregiver burden.

A Swedish doctor presented new evidence Sept. 11 that e-cigarettes containing nicotine cause stiffening of arteries in humans, adding fuel to the debate of whether the smoking alternative is safe.

After spending nearly six years researching the relationship between metabolically healthy obesity and risk of cardiovascular disease, a team of U.K. doctors are suggesting that even “healthy” obese individuals are more prone to develop heart issues.

Children exposed to toxic dust after the attack on New York's World Trade Centers in 2001 are showing early signs of cardiovascular risks, a study suggests.

Apparently, it’s possible to have too much of a good thing. At least that’s what researchers are suggesting about high-density lipoprotein (HDL) cholesterol, widely known as the “good” type of cholesterol.